Hudson Bay Capital Management LP
Position in FOLD — AMICUS THERAPEUTICS, INC.
CIK 1393825
STAMFORD, CT
Position in FOLD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$5,274,140
-$3,590,260 QoQ
Shares Held
364,740
-41.4% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FOLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Hudson Bay Capital Management LP holds $537,145,014 across 151 Biotechnology names. FOLD ranks #27 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
974,776 | $55,065,096 | |
| 2 | APLS |
Apellis Pharmaceuticals, Inc.
|
1,190,416 | $47,890,435 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
32,001 | $24,725,252 | |
| 4 | BNTX |
BioNTech SE
|
275,000 | $24,442,000 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
295,100 | $22,159,059 | |
| 6 | ARGX |
Argenx SE
|
30,000 | $21,907,500 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
45,000 | $20,094,300 | |
| 8 | IMCR |
Immunocore Holdings plc
|
633,174 | $19,090,196 |
All Filings in FOLD
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,274,140 | 364,740 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $8,864,400 | 622,500 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $16,351,000 | 2,075,000 | Shares | Sole | 2025-12-15 | |
| 2025-06-30 | $12,678,713 | 2,212,690 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $20,158,545 | 2,470,410 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $17,001,216 | 1,804,800 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $15,219,000 | 1,425,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $10,589,600 | 1,067,500 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $9,453,450 | 802,500 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,108,400 | 360,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,128,000 | 175,000 | Shares | Sole | 2023-12-07 | |
| 2023-06-30 | $1,946,800 | 155,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,386,250 | 125,000 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $1,526,250 | 125,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,305,000 | 125,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,933,200 | 180,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $462,098 | 48,796 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $2,387,500 | 250,000 | Shares | Sole | 2021-12-29 | |
| 2021-06-30 | $3,036,600 | 315,000 | Shares | Sole | 2021-08-16 | |
| 2020-06-30 | $601,692 | 39,900 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $970,200 | 105,000 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||